21 – 30 of 40
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Clinical Impact of 2-Deoxy-2-[18F]fluoro-D-Glucose (FDG)-Positron Emission Tomography (PET) on Treatment Choice in Recurrent Cancer of the Cervix Uteri.
- Contribution to journal › Article
-
Mark
Panitumumab and Pegylated Liposomal Doxorubicin in Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-Type: The PaLiDo Study, a Phase II Nonrandomized Multicenter Study.
- Contribution to journal › Article
- 2011
-
Mark
Central nervous system metastases from epithelial ovarian cancer : Prognostic factors and outcome
- Contribution to journal › Article
- 2010
-
Mark
Adjuvant chemotherapy in endometrial cancer.
- Contribution to journal › Article
- 2009
-
Mark
Prediction of patient outcome with 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography early during radiotherapy for locally advanced cervical cancer.
- Contribution to journal › Article
-
Mark
Estradiol attenuates EGF-induced rapid uPAR mobilization and cell migration via the G-protein-coupled receptor 30 in ovarian cancer cells.
- Contribution to journal › Article
- 2008
-
Mark
Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel - long-term follow-up
- Contribution to journal › Article
-
Mark
Response to letter of Escobar et al.
- Contribution to journal › Article
- 2007
-
Mark
Ovarian cancer at young age: the contribution of mismatch-repair defects in a population-based series of epithelial ovarian cancer before age 40.
- Contribution to journal › Article
-
Mark
Transvaginal ultrasound and lactate dehydrogenase isoenzyme activity profile in uterine aspirate for diagnosis of endometrial carcinoma in women with postmenopausal bleeding.
- Contribution to journal › Article
